Stuvia.com ik- ikThe ikMarketplace ikto ikBuy ikand ikSell ikyour ikStudy
ikMaterial
MULTIPLE ikCHOICE
DD
oDw
oow
nwlno
nla
loodaaedddeeed
bddybb:yyS
y:::kiu
kAipsre
iharehA|||paaabbpbie
iigeklciatlcyinh1@
@
2@
ggm
m
gmaaiilal..ciclo
.ocm
om
m
m
Distribution ikof ikthis ikdocument ikis ikillegal
, Stuvia.com ik- ikThe ikMarketplace ikto ikBuy ikand ikSell ikyour ikStudy
ikMaterial
1. Who ikfirst ikpopularized ikspirometry ikfor ikthe ikevaluation ikof ikpulmonary ikfunction?
a. August ikand ikMarie ikKrogh
b. Alvan ikBarach
c. John ikSeveringhaus
d. John ikHutchinson
ANS: i k D
Hutchinson ikpopularized ikthe ikconcept ikof ikusing ikVC ikto ikassess iklung ikfunction, ikand ikthe
iknames ikheig
k ave ikto ikseveral ikother iklung ikcompartments ikare ikstill ikused iktoday.
DIF: 1 REF: p. ik2 OBJ: None MSC: i k NBRC: ikNone
2. Which ikof ikthe ikfollowing ikare ikindications ikfor ikperforming ikspirometry?
1. Assess ikthe ikrisk ikof iklung ikresection.
2. Determine ikthe ikresponse ikto ikbronchodilator iktherapy.
3. Assess ikthe ikseverity ikof ikrestrictive iklung ikdisease.
4. Quantify ikthe ikextent ikof ikCOPD.
a. 1 ikand ik4
b. 2 ikand ik3
c. 1, ik2, ikand ik4
d. 2, ik3, ikand ik4
ANS: i k C
Spirometry ikcannot ikassess ikseverity ikof ikrestriction; ikfor ikthat ikyou ikneed ikto ikmeasure iklung
ikvolumesi(
k see ikBox ik1-2, ikChapter ik1).
DIF: 1 REF: p. ik7 OBJ: EL-2 MSC: i k NBRC: ikNone
3. The ikmain ikindication ikfor ikthe ikmeasurement ikof iklung ikvolumes ikis ikto ikdo ikwhich ikof ikthe
ikfollowing?
a. Diagnose ikor ikassess ikthe ikseverity ikof ikrestriction.
b. Evaluate ikthe ikseverity ikof ikpulmonary ikhypertension.
c. Determine ikthe iklevel ikof ikcardiopulmonary ikfitness.
d. Assess ikthe ikrisk ikof ikabdominal iksurgical ikprocedures.
ANS: i k A
The ikmost ikcommon ikreason ikfor ikmeasuring iklung ikvolumes ikis ikto ikidentify ikrestrictive iklung
ik disease.D
ik IF: 1 REF: p. ik35 OBJ: EL-2 MSC: i k NBRC:
None
ik
4. DLCO ikmeasurements ikmay ikbe ikindicated ikto ikevaluate ikpulmonary ikinvolvement ikin ikwhich
ikof ikthef
ik ollowing iksystemic ikdiseases?
a. Asthma
b. Sarcoidosis
c. Exertional ikhypoxemia
DD
oDw
oow
nwlno
nla
loodaaedddeeed
bddybb:yyS
y:::kiu
kAipsre
iharehA|||paaabbpbie
iigeklciatlcyinh1@
@
2@
ggm
m
gmaaiilal..ciclo
.ocm
om
m
m
Distribution ikof ikthis ikdocument ikis ikillegal
, Stuvia.com ik- ikThe ikMarketplace ikto ikBuy ikand ikSell ikyour ikStudy
ikMaterial
d. Guillain-Barré iksyndrome
ANS: i k B
Sarcoidosis ikis ikthe ikonly iksystemic ikdisease iklisted ikthat ikaffects ikgas ikexchange.
DIF: 1 REF: p. ik9 ik| ikp. ik19 ik| ikp. ik21 ik| ikp. ik35 OBJ: EL-
2ikMSC: i k NBRC: ikNone
5. Blood ikgas ikanalysis ikis ikused ikwith ikpatients ikwith ikCOPD ikto ikdo ikwhich ikof ikthe ikfollowing?
a. Monitor ikairway ikresponsiveness.
b. Determine iklevel ikof ikcardiopulmonary ikfitness.
c. Detect ikpulmonary ikhypertension.
d. Assess ikneed ikfor iksupplementary ikO2.
ANS: i k D
Blood ikgas ikanalysis ikis ikmost ikcommonly ikused ikto ikdetermine ikthe ikneed ikfor iksupplemental
ikoxygenia
k nd ikto ikmanage ikpatients ikwho ikrequire ikventilatory iksupport.
DIF: 2 REF: p. ik15 OBJ: EL-
1iM
k SC: i k NBRC: ikCPFT ik2A-2
6. Which ikof ikthe ikfollowing ikcause ikemphysema?
1. 1-Antitrypsin ikdeficiency
2. Exposure ikto ikenvironmental ikpollutants
3. Radiation iktherapy
4. Cigarette iksmoking
a. 1 ikand ik2
b. 3 ikand ik4
c. 1, ik2, ikand ik4
d. 2, ik3, ikand ik4
ANS: i k C
Emphysema ikis ikcaused ikprimarily ikby ikcigarette iksmoking. ikSome ikemphysema ikis ikcaused
ikby iktheia
k bsence ikof ika ikprotective ikenzyme. ikChronic ikexposure ikto ikenvironmental
ikpollutants ikcan ikalso ikcontribute ikto ikthe ikdevelopment ikof ikemphysema.
DIF: 1 REF: p. ik11 OBJ: EL-3 ik| ikAL-2 MSC: i k NBRC: ikNone
7. An ikadult ikpatient ikcomplains ikof ikchest iktightness ikand ikcough ikwhenever ikhe ikjogs ikin ikcold
ikweather.iT
k hese iksymptoms ikare ikconsistent ikwith ikwhich ikof ikthe ikfollowing?
a. Cystic ikfibrosis
b. Asthma
c. Pulmonary ikhypertension
d. Idiopathic ikpulmonary ikfibrosis
ANS: i k B
Agents ikor ikevents ikthat ikcause ikan ikasthmatic ikepisode ikare ikcalled iktriggers ik(see ikBox ik1-7,
ikChapter ik1). ikAntigens iksuch ikas ikanimal ikdander, ikpollens, ikand ikdusts ikare ikthe ikmost ikcommon
iktriggers. ikOtheric
k ommon iktriggers ikinclude ikexposure ikto ikair ikpollutants ikand ikexercise ikin ikcold
ikor ikdry ikair.
DIF: 2 REF: p. ik16 OBJ: EL-3 MSC: i k NBRC: ikNone
DD
oDw
oow
nwlno
nla
loodaaedddeeed
bddybb:yyS
y:::kiu
kAipsre
iharehA|||paaabbpbie
iigeklciatlcyinh1@
@
2@
ggm
m
gmaaiilal..ciclo
.ocm
om
m
m
Distribution ikof ikthis ikdocument ikis ikillegal
, Stuvia.com ik- ikThe ikMarketplace ikto ikBuy ikand ikSell ikyour ikStudy
ikMaterial
8. Which ikof ikthe ikfollowing ikstatements ikconcerning iktumors ikin ikthe ikupper ikairway ikis iktrue?
a. There ikmay ikbe ikvariable ikor ikfixed ikobstruction.
b. Fixed ikobstruction ikwill ikbe ikpresent.
c. Variable ikobstruction ikwill ikbe ikpresent.
d. Small ikairway ikobstruction ikwill ikresult.
ANS: i k A
Tumors ikinvolving ikthe ikupper ikairway ikmay ikcause ikvariable ikor ikfixed ikobstruction.
DIF: 2 REF: p. ik19 OBJ: EL-
2iM
k SC: i k NBRC: ikCPFT ik3C-3
9. Sarcoidosis ikis ika iksystemic ikdisorder ikthat ikusually ikcauses ikwhich ikof ikthe ikfollowing?
a. A ikrestrictive ikventilatory ikdefect
b. An ikobstructive ikventilatory ikdefect
c. Hyperreactive ikairways
d. Primary ikpulmonary ikhypertension
ANS: i k A
Restriction ikis ikoften ikassociated ikwith ikthe ikfollowing: ikinterstitial iklung ikdiseases,
ikincludingii
k diopathic ikfibrosis, ikpneumoconioses, ikand iksarcoidosis.
DIF: 1 REF: p. ik19 ik| ikp. ik21 OBJ: EL-3 MSC: i k NBRC: ikNone
10. For ikwhich ikof ikthe ikfollowing ikconditions ikmight ikpulmonary ikfunction iktesting ikbe
ikcontraindicated?
a. Vocal ikcord ikdysfunction
b. Untreated ikpneumothorax
c. Congestive ikheart ikfailure ik(CHF)
d. Bronchiolitis ikobliterans
ANS: i k B
Pulmonary ikfunction iktests ikare ikusually ikcontraindicated ikin ikthe ikpresence ikof
ikpneumothorax. ikHowever, ikundiagnosed ikpneumothorax ikmay ikpresent ika ikrisk ikif
ikpulmonary ikfunction ikstudies ikareip
k erformed.
DIF: 1 REF: p. ik23 OBJ: EL-
4iM
k SC: i k NBRC: ikCPFT ik2B-6
11. Which ikof ikthe ikfollowing ikcorrectly ikdescribe(s) ikappropriate ikphysical ikmeasurements
ikbeforeip k ulmonary ikfunction iktesting?
1. Actual ikbody ikweight ikshould ikbe ikused ikto ikcalculate ikpredicted ikvalues.
2. Standing ikheight ikshould ikbe ikmeasured ikwhen ikthe ikpatient ikis ikbarefoot.
3. Arm ikspan ikshould ikbe ikused ikinstead ikof ikheight ikfor ika ikpatient ikwith ikkyphosis.
4. Age ikshould ikbe ikrecorded ikto ikthe iknearest ikdecade ik(10 ikyears).
a. 1 ikonly
b. 2 ikand ik3
c. 1, ik2, ikand ik4
d. ik1, ik2, ik3, ikand
4A
ikik NS: i k B
DD
oDw
oow
nwlno
nla
loodaaedddeeed
bddybb:yyS
y:::kiu
kAipsre
iharehA|||paaabbpbie
iigeklciatlcyinh1@
@
2@
ggm
m
gmaaiilal..ciclo
.ocm
om
m
m
Distribution ikof ikthis ikdocument ikis ikillegal
ikMaterial
MULTIPLE ikCHOICE
DD
oDw
oow
nwlno
nla
loodaaedddeeed
bddybb:yyS
y:::kiu
kAipsre
iharehA|||paaabbpbie
iigeklciatlcyinh1@
@
2@
ggm
m
gmaaiilal..ciclo
.ocm
om
m
m
Distribution ikof ikthis ikdocument ikis ikillegal
, Stuvia.com ik- ikThe ikMarketplace ikto ikBuy ikand ikSell ikyour ikStudy
ikMaterial
1. Who ikfirst ikpopularized ikspirometry ikfor ikthe ikevaluation ikof ikpulmonary ikfunction?
a. August ikand ikMarie ikKrogh
b. Alvan ikBarach
c. John ikSeveringhaus
d. John ikHutchinson
ANS: i k D
Hutchinson ikpopularized ikthe ikconcept ikof ikusing ikVC ikto ikassess iklung ikfunction, ikand ikthe
iknames ikheig
k ave ikto ikseveral ikother iklung ikcompartments ikare ikstill ikused iktoday.
DIF: 1 REF: p. ik2 OBJ: None MSC: i k NBRC: ikNone
2. Which ikof ikthe ikfollowing ikare ikindications ikfor ikperforming ikspirometry?
1. Assess ikthe ikrisk ikof iklung ikresection.
2. Determine ikthe ikresponse ikto ikbronchodilator iktherapy.
3. Assess ikthe ikseverity ikof ikrestrictive iklung ikdisease.
4. Quantify ikthe ikextent ikof ikCOPD.
a. 1 ikand ik4
b. 2 ikand ik3
c. 1, ik2, ikand ik4
d. 2, ik3, ikand ik4
ANS: i k C
Spirometry ikcannot ikassess ikseverity ikof ikrestriction; ikfor ikthat ikyou ikneed ikto ikmeasure iklung
ikvolumesi(
k see ikBox ik1-2, ikChapter ik1).
DIF: 1 REF: p. ik7 OBJ: EL-2 MSC: i k NBRC: ikNone
3. The ikmain ikindication ikfor ikthe ikmeasurement ikof iklung ikvolumes ikis ikto ikdo ikwhich ikof ikthe
ikfollowing?
a. Diagnose ikor ikassess ikthe ikseverity ikof ikrestriction.
b. Evaluate ikthe ikseverity ikof ikpulmonary ikhypertension.
c. Determine ikthe iklevel ikof ikcardiopulmonary ikfitness.
d. Assess ikthe ikrisk ikof ikabdominal iksurgical ikprocedures.
ANS: i k A
The ikmost ikcommon ikreason ikfor ikmeasuring iklung ikvolumes ikis ikto ikidentify ikrestrictive iklung
ik disease.D
ik IF: 1 REF: p. ik35 OBJ: EL-2 MSC: i k NBRC:
None
ik
4. DLCO ikmeasurements ikmay ikbe ikindicated ikto ikevaluate ikpulmonary ikinvolvement ikin ikwhich
ikof ikthef
ik ollowing iksystemic ikdiseases?
a. Asthma
b. Sarcoidosis
c. Exertional ikhypoxemia
DD
oDw
oow
nwlno
nla
loodaaedddeeed
bddybb:yyS
y:::kiu
kAipsre
iharehA|||paaabbpbie
iigeklciatlcyinh1@
@
2@
ggm
m
gmaaiilal..ciclo
.ocm
om
m
m
Distribution ikof ikthis ikdocument ikis ikillegal
, Stuvia.com ik- ikThe ikMarketplace ikto ikBuy ikand ikSell ikyour ikStudy
ikMaterial
d. Guillain-Barré iksyndrome
ANS: i k B
Sarcoidosis ikis ikthe ikonly iksystemic ikdisease iklisted ikthat ikaffects ikgas ikexchange.
DIF: 1 REF: p. ik9 ik| ikp. ik19 ik| ikp. ik21 ik| ikp. ik35 OBJ: EL-
2ikMSC: i k NBRC: ikNone
5. Blood ikgas ikanalysis ikis ikused ikwith ikpatients ikwith ikCOPD ikto ikdo ikwhich ikof ikthe ikfollowing?
a. Monitor ikairway ikresponsiveness.
b. Determine iklevel ikof ikcardiopulmonary ikfitness.
c. Detect ikpulmonary ikhypertension.
d. Assess ikneed ikfor iksupplementary ikO2.
ANS: i k D
Blood ikgas ikanalysis ikis ikmost ikcommonly ikused ikto ikdetermine ikthe ikneed ikfor iksupplemental
ikoxygenia
k nd ikto ikmanage ikpatients ikwho ikrequire ikventilatory iksupport.
DIF: 2 REF: p. ik15 OBJ: EL-
1iM
k SC: i k NBRC: ikCPFT ik2A-2
6. Which ikof ikthe ikfollowing ikcause ikemphysema?
1. 1-Antitrypsin ikdeficiency
2. Exposure ikto ikenvironmental ikpollutants
3. Radiation iktherapy
4. Cigarette iksmoking
a. 1 ikand ik2
b. 3 ikand ik4
c. 1, ik2, ikand ik4
d. 2, ik3, ikand ik4
ANS: i k C
Emphysema ikis ikcaused ikprimarily ikby ikcigarette iksmoking. ikSome ikemphysema ikis ikcaused
ikby iktheia
k bsence ikof ika ikprotective ikenzyme. ikChronic ikexposure ikto ikenvironmental
ikpollutants ikcan ikalso ikcontribute ikto ikthe ikdevelopment ikof ikemphysema.
DIF: 1 REF: p. ik11 OBJ: EL-3 ik| ikAL-2 MSC: i k NBRC: ikNone
7. An ikadult ikpatient ikcomplains ikof ikchest iktightness ikand ikcough ikwhenever ikhe ikjogs ikin ikcold
ikweather.iT
k hese iksymptoms ikare ikconsistent ikwith ikwhich ikof ikthe ikfollowing?
a. Cystic ikfibrosis
b. Asthma
c. Pulmonary ikhypertension
d. Idiopathic ikpulmonary ikfibrosis
ANS: i k B
Agents ikor ikevents ikthat ikcause ikan ikasthmatic ikepisode ikare ikcalled iktriggers ik(see ikBox ik1-7,
ikChapter ik1). ikAntigens iksuch ikas ikanimal ikdander, ikpollens, ikand ikdusts ikare ikthe ikmost ikcommon
iktriggers. ikOtheric
k ommon iktriggers ikinclude ikexposure ikto ikair ikpollutants ikand ikexercise ikin ikcold
ikor ikdry ikair.
DIF: 2 REF: p. ik16 OBJ: EL-3 MSC: i k NBRC: ikNone
DD
oDw
oow
nwlno
nla
loodaaedddeeed
bddybb:yyS
y:::kiu
kAipsre
iharehA|||paaabbpbie
iigeklciatlcyinh1@
@
2@
ggm
m
gmaaiilal..ciclo
.ocm
om
m
m
Distribution ikof ikthis ikdocument ikis ikillegal
, Stuvia.com ik- ikThe ikMarketplace ikto ikBuy ikand ikSell ikyour ikStudy
ikMaterial
8. Which ikof ikthe ikfollowing ikstatements ikconcerning iktumors ikin ikthe ikupper ikairway ikis iktrue?
a. There ikmay ikbe ikvariable ikor ikfixed ikobstruction.
b. Fixed ikobstruction ikwill ikbe ikpresent.
c. Variable ikobstruction ikwill ikbe ikpresent.
d. Small ikairway ikobstruction ikwill ikresult.
ANS: i k A
Tumors ikinvolving ikthe ikupper ikairway ikmay ikcause ikvariable ikor ikfixed ikobstruction.
DIF: 2 REF: p. ik19 OBJ: EL-
2iM
k SC: i k NBRC: ikCPFT ik3C-3
9. Sarcoidosis ikis ika iksystemic ikdisorder ikthat ikusually ikcauses ikwhich ikof ikthe ikfollowing?
a. A ikrestrictive ikventilatory ikdefect
b. An ikobstructive ikventilatory ikdefect
c. Hyperreactive ikairways
d. Primary ikpulmonary ikhypertension
ANS: i k A
Restriction ikis ikoften ikassociated ikwith ikthe ikfollowing: ikinterstitial iklung ikdiseases,
ikincludingii
k diopathic ikfibrosis, ikpneumoconioses, ikand iksarcoidosis.
DIF: 1 REF: p. ik19 ik| ikp. ik21 OBJ: EL-3 MSC: i k NBRC: ikNone
10. For ikwhich ikof ikthe ikfollowing ikconditions ikmight ikpulmonary ikfunction iktesting ikbe
ikcontraindicated?
a. Vocal ikcord ikdysfunction
b. Untreated ikpneumothorax
c. Congestive ikheart ikfailure ik(CHF)
d. Bronchiolitis ikobliterans
ANS: i k B
Pulmonary ikfunction iktests ikare ikusually ikcontraindicated ikin ikthe ikpresence ikof
ikpneumothorax. ikHowever, ikundiagnosed ikpneumothorax ikmay ikpresent ika ikrisk ikif
ikpulmonary ikfunction ikstudies ikareip
k erformed.
DIF: 1 REF: p. ik23 OBJ: EL-
4iM
k SC: i k NBRC: ikCPFT ik2B-6
11. Which ikof ikthe ikfollowing ikcorrectly ikdescribe(s) ikappropriate ikphysical ikmeasurements
ikbeforeip k ulmonary ikfunction iktesting?
1. Actual ikbody ikweight ikshould ikbe ikused ikto ikcalculate ikpredicted ikvalues.
2. Standing ikheight ikshould ikbe ikmeasured ikwhen ikthe ikpatient ikis ikbarefoot.
3. Arm ikspan ikshould ikbe ikused ikinstead ikof ikheight ikfor ika ikpatient ikwith ikkyphosis.
4. Age ikshould ikbe ikrecorded ikto ikthe iknearest ikdecade ik(10 ikyears).
a. 1 ikonly
b. 2 ikand ik3
c. 1, ik2, ikand ik4
d. ik1, ik2, ik3, ikand
4A
ikik NS: i k B
DD
oDw
oow
nwlno
nla
loodaaedddeeed
bddybb:yyS
y:::kiu
kAipsre
iharehA|||paaabbpbie
iigeklciatlcyinh1@
@
2@
ggm
m
gmaaiilal..ciclo
.ocm
om
m
m
Distribution ikof ikthis ikdocument ikis ikillegal
